Our data showed that NAF1 expressions were decreased upon c-Myc or NRF2 knockdown in glioma cells, while the mRNA and protein levels of NAF1 were increased upon overexpression of c-Myc or NRF2, suggesting that NAF1 may be a potential target of c-Myc and NRF2. Here, MYC is linked to central nervous system cancer.